Neurostimulation Market Growth, Size, Share, Trends, and Forecast 2032

Neurostimulation Market: Industry Perspective:

The global Neurostimulation market size accrued earnings worth approximately USD 6.64 Billion in 2023 and is predicted to gain revenue of about USD 19.11 Billion by 2032, is set to record a CAGR of nearly 12.58% over the period from 2024 to 2032.

Request Free Sample

Global Neurostimulation Market: Overview

The treatment of various illnesses such as incontinence, epilepsy, essential tremors, gastroparesis, Parkinson’s disease, and depression use neurostimulation. Neurostimulation is a high-potential treatment in which the patients find relief from their pain, which is not obtained by surgical therapies and medications. The life quality of the patients, who are paralyzed or suffering from loss of sense organs, is improved highly. Hence, neurostimulation is highly influential in hearing aids, artificial vision, artificial limbs, and others.

Global Neurostimulation Market: Growth Factors

The global neurostimulation market is growing tremendously. The pain management application is the largest application in the global market. The rise in the occurrences of chronic pain and the increase in the usage of neurostimulation therapies are some of the factors that are driving global market growth. The sacral nerve stimulator segment is also rapidly growing. This growth is owing to the rise in the number of patients with fecal and urinary incontinence.

The other factors that are driving the global market growth are the rise in the aging population that is having neurological disorders and the need for neurological care.Request Free Sample

Developments in neurology have been observed owing to the rising awareness among people about enhanced clinical outcomes. The other reason for the global market growth is the rise in the diseases such as epilepsy and migraine, Alzheimer’s, and Parkinson’s which in turn increases the demand for neurostimulation devices. Various technological advancements and researchers have contributed a major share in the global neurostimulation market growth.

To know more about this report, request a sample copy.

Neurosimulation Market: Report Scope

Global Neurostimulation Market: Segmentation

The global neurostimulation market is segmented on the basis of therapies, applications, and regions.

On the basis of the therapies, the global market is categorized into the spinal cord, sacral nerve, transcranial magnetic, TENS, deep brain, vagus nerve, and gastric.

Based on the applications, the global neurostimulation market is segregated into epilepsy, urinary and fecal incontinence, dystonia, Parkinson’s disease, pain management, essential tremor, depression, gastroparesis, and others.

Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Regional Analysis

The global neurostimulation market is standing strong in the North American region which is followed by Europe and Asia-Pacific. The growth in the Asia-Pacific region is tremendously fast, especially in countries such as India, China, and Brazil.

The growth in this region is mainly owing to the growing awareness among people about neurostimulation, which acts as an alternative treatment for neurological disorders and chronic pain.

In the North American region, the U.S. contributes the largest share in the global neurostimulation market growth, which is followed by Germany.

The factors that are contributing to the global market growth are the advanced healthcare infrastructure and the high occurrences of diseases such as a migraine, Alzheimer’s, epilepsy, and Parkinson’s disease.

Global Neurostimulation Market: Competitive Players

Some main participants of the

• Cyberonics Inc.
• Medtronic Inc.
• CVRx Inc.
• Boston Scientific Corp.
• St. Jude Medical Inc.
• and Neuropace Inc
• Aleva Neurotherapeutics SA
• Bioness Inc.
• EnteroMedics Inc.
• NeuroSigma Inc.
• BioControl Medical
• LivaNova PLC
• and Synapse Biomedical Inc, among others.

Segments Included in Report

By Therapies

• Spinal Cord
• Sacral Nerve
• Transcranial Magnetic
• TENS
• Deep Brain
• Vagus Nerve & Gastric

By Application

• Epilepsy
• Urinary & Fecal Incontinence
• Dystonia
• Parkinson’s Disease
• Pain Management
• Essential Tremor
• Depression
• Gastroparesis
• Others

Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa